188 related articles for article (PubMed ID: 37232164)
1. Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma.
Zhang Y; Wang H; Lu J; Lv Q; Yun B; Ge Z; Yan L
Int J Immunopathol Pharmacol; 2023; 37():3946320231178131. PubMed ID: 37232164
[No Abstract] [Full Text] [Related]
2. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
[TBL] [Abstract][Full Text] [Related]
3. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
[TBL] [Abstract][Full Text] [Related]
5. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis.
Wu C; Ma C; Yuan J; Zhou P
Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296
[TBL] [Abstract][Full Text] [Related]
6. Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network.
Dong Y; Wen W; Yuan T; Liu L; Li X
Dis Markers; 2023; 2023():1766080. PubMed ID: 36817087
[TBL] [Abstract][Full Text] [Related]
7. Pain-Related Gene Solute Carrier Family 24 Member 3 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma: A Study via Integrated Bioinformatics Analyses and Experimental Verification.
Zhou S; Jin Q; Yao H; Ying J; Tian L; Jiang X; Yang Y; Jiang X; Gao W; Zhang W; Zhu Y; Cao W
Comput Math Methods Med; 2023; 2023():4164232. PubMed ID: 36798148
[TBL] [Abstract][Full Text] [Related]
8. ZNF695, A Potential Prognostic Biomarker, Correlates with Immune Infiltrates in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma: Bioinformatic Analysis and Experimental Verification.
Ding X; Wan A; Qi X; Jiang K; Liu Z; Chen B
Curr Gene Ther; 2024 Mar; ():. PubMed ID: 38441026
[TBL] [Abstract][Full Text] [Related]
9. MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
Gong M; Shen F; Li Y; Ming L; Hong L
PLoS One; 2023; 18(8):e0290462. PubMed ID: 37594950
[TBL] [Abstract][Full Text] [Related]
10. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid synthase (FASN) inhibits the cervical squamous cell carcinoma (CESC) progression through the Akt/mTOR signaling pathway.
Lin Q; Jiang Y; Zhou F; Zhang Y
Gene; 2023 Jan; 851():147023. PubMed ID: 36375657
[TBL] [Abstract][Full Text] [Related]
12. Exploring Immune-Related Gene Profiling and Infiltration of Immune Cells in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Li J; Xi J
Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38275602
[TBL] [Abstract][Full Text] [Related]
13. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
14. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration.
Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559
[No Abstract] [Full Text] [Related]
16. Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma.
Li CJ; Chang CH; Tsang YL; Fang SH; Chen SN; Chiang AJ
Int Immunopharmacol; 2022 Nov; 112():109273. PubMed ID: 36183678
[TBL] [Abstract][Full Text] [Related]
17. The New Biomarker for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Based on Public Database Mining.
Ding H; Xiong XX; Fan GL; Yi YX; Chen YR; Wang JT; Zhang W
Biomed Res Int; 2020; 2020():5478574. PubMed ID: 32351997
[TBL] [Abstract][Full Text] [Related]
18. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Zhou J; Xu L; Zhou H; Wang J; Xing X
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510286
[TBL] [Abstract][Full Text] [Related]
20. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.
Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J
Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
